Search - tctmd.com

Displaying 381 - 400 of 422

Sort: Relevancy | Date

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

L.A. McKeown

September 16, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Jason Kahn

August 08, 2011

News Daily News

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

L.A. McKeown

August 02, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Industry News

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

June 15, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

Advertisement

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

First DES for Above-the-Knee Vascular Disease on the Horizon

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Long-term Antiplatelet Therapy: All Risk, No Benefit

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

Women Have Less Neointimal Hyperplasia Than Men With ZES

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

DES Show Advantage over BMS for Heart Transplant Complication

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

EES Show Long-term Safety Advantage over SES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content